BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23391264)

  • 1. Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors.
    Nambu A; Onishi H; Aoki S; Tominaga L; Kuriyama K; Araya M; Saito R; Maehata Y; Komiyama T; Marino K; Koshiishi T; Sawada E; Araki T
    BMC Cancer; 2013 Feb; 13():68. PubMed ID: 23391264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
    Kim SS; Song SY; Kwak J; Ahn SD; Kim JH; Lee JS; Kim WS; Kim SW; Choi EK
    Lung Cancer; 2013 Feb; 79(2):161-6. PubMed ID: 23182662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
    Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
    J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients.
    Nambu A; Onishi H; Aoki S; Koshiishi T; Kuriyama K; Komiyama T; Marino K; Araya M; Saito R; Tominaga L; Maehata Y; Sawada E; Araki T
    Radiat Oncol; 2011 Oct; 6():137. PubMed ID: 21995807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
    Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer.
    Miura H; Inoue T; Shiomi H; Oh RJ
    J Radiat Res; 2015 Mar; 56(2):332-7. PubMed ID: 25504640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.
    Taremi M; Hope A; Lindsay P; Dahele M; Fung S; Purdie TG; Jaffray D; Dawson L; Bezjak A
    Radiat Oncol; 2012 Sep; 7():159. PubMed ID: 22985910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
    Park Y; Kim HJ; Chang AR
    Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
    Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
    Pettersson N; Nyman J; Johansson KA
    Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
    Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.
    Coroller TP; Mak RH; Lewis JH; Baldini EH; Chen AB; Colson YL; Hacker FL; Hermann G; Kozono D; Mannarino E; Molodowitch C; Wee JO; Sher DJ; Killoran JH
    PLoS One; 2014; 9(4):e94859. PubMed ID: 24728448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Chest Wall Toxicity During Long-term Follow Up After Thoracic Stereotactic Body Radiation Therapy.
    Chipko C; Ojwang J; Gharai LR; Deng X; Mukhopadhyay N; Weiss E
    Pract Radiat Oncol; 2019 May; 9(3):e338-e346. PubMed ID: 30731275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Manyam BV; Videtic GMM; Verdecchia K; Reddy CA; Woody NM; Stephans KL
    Pract Radiat Oncol; 2019 Mar; 9(2):e187-e195. PubMed ID: 30529796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.
    Voroney JP; Hope A; Dahele MR; Purdie TG; Franks KN; Pearson S; Cho JB; Sun A; Payne DG; Bissonnette JP; Bezjak A; Brade AM
    J Thorac Oncol; 2009 Aug; 4(8):1035-7. PubMed ID: 19633478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
    Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
    J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and characteristics of Rib fracture following SBRT for lung tumors.
    Carducci MP; Sundaram B; Greenberger BA; Werner-Wasik M; Kane GC
    BMC Cancer; 2023 Apr; 23(1):337. PubMed ID: 37046249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy.
    Podder T; Biswas T; Yao M; Zhang Y; Kim E; Ellis RJ; Lo SS; Machtay M
    Future Oncol; 2014 Dec; 10(15):2311-7. PubMed ID: 25525841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.